Upregulation of type III endothelial cell nitric oxide synthase by HMG-CoA reductase inhibitors

Details for Australian Patent Application No. 2003203411 (hide)

International Classifications

Event Publications

17 April 2003 Complete Application Filed

12 June 2003 Application Open to Public Inspection

Published as AU-A-2003203411

2 March 2006 Amendment Made

The nature of the amendment is: Amend the name of the applicant The General Hospital Corporation and Brigham and Women's Hospital to The General Hospital Corporation and The Brigham and Women's Hospital, Inc.

31 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.